BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 25257635)

  • 1. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.
    Meredith Am IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Allocco DJ; Dawkins KD
    J Am Coll Cardiol; 2014 Sep; 64(13):1339-48. PubMed ID: 25257635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
    Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study.
    Meredith IT; Worthley SG; Whitbourn RJ; Antonis P; Montarello JK; Newcomb AE; Lockwood S; Haratani N; Allocco DJ; Dawkins KD
    EuroIntervention; 2014 Mar; 9(11):1264-70. PubMed ID: 24169077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve.
    Schofer J; Colombo A; Klugmann S; Fajadet J; DeMarco F; Tchétché D; Maisano F; Bruschi G; Latib A; Bijuklic K; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Lefevre T
    J Am Coll Cardiol; 2014 Mar; 63(8):763-8. PubMed ID: 24211506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients.
    Meredith IT; Dumonteil N; Blackman DJ; Tchétché D; Walters DL; Hildick-Smith D; Manoharan G; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Modine T; Van Mieghem NM; Feldman T; Allocco DJ; Dawkins KD
    EuroIntervention; 2017 Sep; 13(7):788-795. PubMed ID: 28555592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).
    Blackman DJ; Meredith IT; Dumonteil N; Tchétché D; Hildick-Smith D; Spence MS; Walters DL; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Houle VM; Allocco DJ; Dawkins KD
    Am J Cardiol; 2017 Jul; 120(2):292-299. PubMed ID: 28535962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
    Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
    Popma JJ; Adams DH; Reardon MJ; Yakubov SJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Kafi A; Schreiber T; Gleason TG; Conte J; Buchbinder M; Deeb GM; Carabello B; Serruys PW; Chenoweth S; Oh JK;
    J Am Coll Cardiol; 2014 May; 63(19):1972-81. PubMed ID: 24657695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
    Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
    JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
    Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
    JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter aortic valve implantation without balloon predilation: a single-center pilot experience.
    Mendiz OA; Fraguas H; Lev GA; Valdivieso LR; Favaloro RR
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):292-7. PubMed ID: 23554013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System.
    Jarr KU; Leuschner F; Meder B; Katus HA; Bekeredjian R; Chorianopoulos E
    J Invasive Cardiol; 2017 Jan; 29(1):30-35. PubMed ID: 27845874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes in Patients Treated With a Repositionable and Fully Retrievable Aortic Valve - REPRISE Japan Study.
    Saito S; Hayashida K; Takayama M; Goto T; Ihlberg L; Sawa Y
    Circ J; 2021 Jun; 85(7):991-1000. PubMed ID: 33191317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial.
    Rizik DG; Rajagopal V; Makkar RR; Bajwa T; Kleiman NS; Linke A; Kereiakes DJ; Waksman R; Thourani VH; Stoler RC; Mishkel GJ; Iyer VS; Buchbinder M; Götberg M; Bjursten H; Allocco DJ; Reardon MJ
    JAMA Netw Open; 2022 Oct; 5(10):e2238792. PubMed ID: 36301543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the Lotus Valve System for treatment of patients with severe aortic valve stenosis and intermediate surgical risk: Results from the Nordic Lotus-TAVR registry.
    De Backer O; Götberg M; Ihlberg L; Packer E; Savontaus M; Nielsen NE; Jørgensen TH; Nykänen A; Baranowski J; Niemelä M; Eskola M; Bjursten H; Søndergaard L
    Int J Cardiol; 2016 Sep; 219():92-7. PubMed ID: 27288972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve.
    Treede H; Tübler T; Reichenspurner H; Grube E; Pascotto A; Franzen O; Mueller R; Low R; Bolling SF; Meinertz T; Schofer J
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):897-903. PubMed ID: 20392455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system.
    Binder RK; Schäfer U; Kuck KH; Wood DA; Moss R; Leipsic J; Toggweiler S; Freeman M; Ostry AJ; Frerker C; Willson AB; Webb JG
    JACC Cardiovasc Interv; 2013 Mar; 6(3):301-7. PubMed ID: 23517843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.